MyAverix Finance
US · Healthcare
Tectonic Therapeutic, Inc. (TECX)
Biotechnology
Tectonic Therapeutic, Inc. (TECX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TECX
Tectonic Therapeutic, Inc. (TECX) — FAQ
What is TECX's P/E ratio?
The price-to-earnings (P/E) ratio for Tectonic Therapeutic, Inc. (TECX) is 25.00 (data as of 2026-05-23).
Does Tectonic Therapeutic, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Tectonic Therapeutic, Inc. (TECX). Check the MyAverix Finance app for the latest dividend data.
What sector is Tectonic Therapeutic, Inc. in?
Tectonic Therapeutic, Inc. (TECX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TECX listed on?
TECX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.